Online citations, reference lists, and bibliographies.

Ocular Culture-proven Endogenous Endophthalmitis: A 5-year Retrospective Study Of The Microorganism Spectrum At A Tertiary Referral Center In Turkey

Hande Celiker, Haluk Kazokoğlu
Published 2018 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
PurposeThe aim of this study was to review the clinical profile of endogenous endophthalmitis (EE), including predisposing systemic conditions, responsible microorganisms, clinical presentations, and outcomes.MethodsWe reviewed data from 21 eyes of 15 patients diagnosed with EE and compared their clinical characteristics over a 5-year period. All patients were ocular fluid cultures proven. Generalized estimating equations (GEE) were used to analyze the effects of vitrectomy, diabetes, malignity, and clinical presentation condition on VA.ResultsDiabetes was the most common illness of EE patients (40.0%). In this geographical region, Pseudomonas aeruginosa (4.8%), Methicillin-sensitive Staphylococcus aureus (4.8%), Methicillin-resistant Staphylococcus aureus (4.8%), and Mycobacterium tuberculosis (4.8%) were identified as causative bacterial microorganisms (n = 5) in patients with EE, and Candida Species (71.4%) and Aspergillus (4.8%) were identified as causative fungal microorganisms (n = 16) in patients with EE in the vitreous specimens. Fungemia (76.2%) (especially yeasts) was the most common extraocular infection source among patients with EE. Fourteen eyes (66.7%) were managed with intravitreal injections of antimicrobial medicines, and seven eyes (33.3%) also underwent vitrectomy. GEE models revealed that logMAR final VA values were found as lower than initial VA assessments.ConclusionDepending on the different regions of the world, the characteristics of disease have been declared invariable. This study provides information about the clinical and microbiological profile of ocular culture-proven EE patients in a region of straddling the Asia and European continents. Aggressive medical and surgical treatment may result in favorable outcomes.
This paper references
10.1038/eye.2010.145
Endogenous endophthalmitis: 10-year experience at a tertiary referral centre
Paul P. Connell (2011)
10.1016/j.addr.2006.07.027
Challenges and obstacles of ocular pharmacokinetics and drug delivery.
Arto Urtti (2006)
10.1016/s0161-6420(13)31255-x
Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study.
Annabelle A Okada (1994)
10.1016/j.survophthal.2014.06.002
Systematic review of 342 cases of endogenous bacterial endophthalmitis.
Timothy L Jackson (2014)
10.1097/APO.0000000000000120
Endogenous Endophthalmitis: A 10-Year Retrospective Study at a Tertiary Hospital in South India.
Dhanashree Ratra (2015)
10.1016/j.ajo.2014.11.032
Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States.
Kamyar Vaziri (2015)
10.1097/ICB.0000000000000238
THE ROLE OF EARLY VITRECTOMY IN THE TREATMENT OF FUNGAL ENDOGENOUS ENDOPHTHALMITIS.
Faith A. Birnbaum (2016)
10.1093/cid/ciq204
Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.
James Riddell (2011)
10.1097/IAE.0000000000000919
PROSPECTIVE TRIAL OF ENDOGENOUS FUNGAL ENDOPHTHALMITIS AND CHORIORETINITIS RATES, CLINICAL COURSE, AND OUTCOMES IN PATIENTS WITH FUNGEMIA.
Yannis M. Paulus (2016)
10.1097/00006982-200406000-00008
A 10-year comparison of endogenous endophthalmitis outcomes: an east Asian experience with Klebsiella pneumoniae infection.
Yung-Jen Chen (2004)
10.1080/09273948.2016.1195000
Endogenous Endophthalmitis in the American and Korean Population: An 8-year Retrospective Study
Heeyoon Cho (2018)
10.1093/infdis/162.1.115
The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome.
S K Shrader (1990)
10.1016/S0161-6420(00)00216-5
Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction.
Joelle Fui Sze Wong (2000)
10.1097/00005792-200303000-00004
Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center.
Monica I Binder (2003)
10.1016/S0039-6257(03)00054-7
Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases.
Timothy L Jackson (2003)
10.1016/j.ajo.2017.11.021
Endophthalmitis: Then and Now.
Nidhi Relhan (2018)
10.1097/IAE.0b013e3181dd6db6
Endogenous endophthalmitis associated with intravenous drug abuse: seven-year experience at a tertiary referral center.
Paul P. Connell (2010)
10.1186/s12348-015-0063-y
Endogenous endophthalmitis: diagnosis, management, and prognosis
Mohammad Ali A. Sadiq (2015)
Endogenous endophthalmitis in the Korean population: a 6-year retrospective study. Retina 34:592–602
HW Lim (2014)
10.1007/s00417-014-2658-7
Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK
Anand Gupta (2014)
10.1186/1869-5760-3-60
Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections
Jayanth Sridhar (2013)
Endophthalmitis patients seen in a tertiary eye care centre in Odisha: A clinico-microbiological analysis
Savitri Sharma (2014)
10.1097/IAE.0b013e3182a2e705
Endogenous endophthalmitis in the Korean population: a six-year retrospective study.
Han Woong Lim (2014)
10.1080/09273948.2016.1196711
Role of Regulatory T Cells in Tubercular Uveitis
Ravi Kumar Sharma (2018)
10.1016/j.ajo.2003.11.013
Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes.
Vivian Schiedler (2004)
10.1097/IAE.0000000000000084
Endogenous endophthalmitis associated with intravenous drug abuse.
Shriji Patel (2014)
10.1016/j.ajo.2011.06.020
Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes.
Ahila Lingappan (2012)
10.3928/1542-8877-19970301-03
Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis.
T F Essman (1997)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar